⌘K
Loading ticker…
NovoCure Limited Ordinary Shares · Healthcare · Medical Equipment
As of 2026-06-26, NovoCure Limited Ordinary Shares (NVCR) has a 3-month relative strength percentile of 81 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 55. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.2%, relative volume 1.92×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 81, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
NVCR is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $37M notional. Top 3 carry $79M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $37M |
| VBVanguard Small Cap ETF | 0.02% | $27M |
| VBKVanguard Small-Cap Growth ETF | 0.04% | $15M |
| VXFVanguard Extended Market ETF | 0.02% | $12M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NVCR Jan avg: -1.07% median: -5.43% win: 25% σ: 17.91% n: 4 2022-04-12 → 2026-05-29 | NVCR Feb avg: -4.40% median: -2.80% win: 50% σ: 16.97% n: 4 2022-04-12 → 2026-05-29 | NVCR Mar avg: -11.65% median: -13.41% win: 25% σ: 11.45% n: 4 2022-04-12 → 2026-05-29 | NVCR Apr avg: 4.47% median: 1.80% win: 60% σ: 22.78% n: 5 2022-04-12 → 2026-05-29 | NVCR May avg: 22.23% median: 8.97% win: 100% σ: 32.32% n: 5 2022-04-12 → 2026-05-29 | NVCR Jun avg: -21.19% median: -17.85% win: 0% σ: 15.35% n: 4 2022-04-12 → 2026-05-29 (current) | NVCR Jul avg: -6.40% median: -11.76% win: 25% σ: 29.47% n: 4 2022-04-12 → 2026-05-29 | NVCR Aug avg: -4.92% median: -4.03% win: 50% σ: 23.41% n: 4 2022-04-12 → 2026-05-29 | NVCR Sep avg: -12.27% median: -13.54% win: 25% σ: 13.88% n: 4 2022-04-12 → 2026-05-29 | NVCR Oct avg: -7.09% median: -4.94% win: 0% σ: 7.49% n: 4 2022-04-12 → 2026-05-29 | NVCR Nov avg: 8.25% median: 4.37% win: 50% σ: 17.21% n: 4 2022-04-12 → 2026-05-29 | NVCR Dec avg: 16.69% median: 11.31% win: 75% σ: 24.14% n: 4 2022-04-12 → 2026-05-29 |